Overview

Ceribell has invested more than a decade in developing point-of-care EEG technology to improve the diagnosis and management of patients with serious neurological conditions. To protect these innovations and ensure fair competition, we have filed complaints with the U.S. International Trade Commission and the U.S. District Court in Delaware against Natus Medical Incorporated. This page provides updates and resources related to the litigation. 

Ceribell Press Release

July 7, 2025 

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware 
https://investors.ceribell.com/news-releases/news-release-details/ceribell-files-complaints-against-natus-medical-incorporated-us